Back to Results
First PageMeta Content
Crisis / Financial crisis / Risk / Acute lymphoblastic leukemia / Pfizer / Pharmaceutical industry / Andrew Lo / Leukemia / Management / Ethics / Economics


New Models for Financing Biopharmaceutical R&D Andrew W. Lo, MIT (based on joint work with Jayna Cummings, David Fagnan, Jose-Maria Fernandez, Carole Ho, Austin Gromatzky, Ken Kosik, Roger Stein)
Add to Reading List

Document Date: 2014-06-25 22:18:14


Open Document

File Size: 2,81 MB

Share Result on Facebook

Company

Pfizer Cambridge Collaborative Innovation Event MIT Laboratory / Biopharma Investments / Merck / New York Times / /

Country

United States / /

Event

FDA Phase / /

Facility

Wash U. Genome Institute / /

IndustryTerm

pharmaceutical industry / pharmaceutical research / finance professionals / /

MarketIndex

NYSE/ARCA Pharma / /

MedicalCondition

acute lymphoblastic leukemia / leukemia / First cancer / /

MedicalTreatment

immunotherapy / /

Organization

FDA / Wash U. Genome Institute / MIT / /

Person

Roger Stein / Austin Gromatzky / Carole Ho / Robert J. Shiller / David Aponte / Jose-Maria Fernandez / David Fagnan / Judy Lewent / Ken Kosik / Andrew W. Lo / Lukas Wartman / Jayna Cummings / /

Position

CFO / /

Product

Avastin / Gleevec / Sutent / Slide / RCC / Rights Reserved Slide / /

Technology

Drug Development / /

SocialTag